NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis $14.22 -0.35 (-2.37%) As of 11:22 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Surgery Partners Stock (NASDAQ:SGRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Surgery Partners alerts:Sign Up Key Stats Today's Range$14.12▼$14.5250-Day Range$13.25▼$16.6452-Week Range$11.41▼$23.44Volume388,162 shsAverage Volume1.74 million shsMarket Capitalization$1.86 billionP/E RatioN/ADividend YieldN/APrice Target$19.00Consensus RatingModerate Buy Company Overview Surgery Partners, Inc. (NASDAQ: SGRY) is a healthcare services company that owns and operates a network of ambulatory surgery centers and surgical hospitals in the United States. The company works with physicians and health systems to provide outpatient and same-day surgical care in settings outside traditional hospital facilities. Its services cover a range of specialties, including orthopedics, pain management, gastroenterology, ophthalmology, gynecology, urology and other procedural areas. Surgery Partners’ facilities generally provide preoperative, surgical and post-anesthesia care, along with related ancillary services. Founded in 2004, Surgery Partners has expanded through the development, acquisition and operation of surgical facilities and partnerships with physicians and healthcare organizations. Its operations are concentrated across multiple states in the U.S., with a focus on delivering cost-conscious procedural care and improving access to outpatient healthcare services.AI Generated. May Contain Errors. Read More Surgery Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScoreSGRY MarketRank™: Surgery Partners scored higher than 70% of companies evaluated by MarketBeat, and ranked 202nd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on no strong buy ratings, 7 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialSurgery Partners has a consensus price target of $19.00, representing about 33.0% upside from its current price of $14.29.Amount of Analyst CoverageSurgery Partners has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Surgery Partners' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth4.00% Earnings GrowthEarnings for Surgery Partners are expected to grow by 4.00% in the coming year, from $0.25 to $0.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -20.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -20.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 4.89. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Surgery Partners' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.10% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 4.68.Change versus previous monthShort interest in Surgery Partners has recently increased by 2.39%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.10 News SentimentSurgery Partners has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Surgery Partners this week, compared to 4 articles on an average week.Search Interest2 people have searched for SGRY on MarketBeat in the last 30 days. Company Ownership2.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $143,500.00 in company stock, which represents 0.0077% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $143,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders2.00% of the stock of Surgery Partners is held by insiders.Percentage Held by InstitutionsSurgery Partners has minimal institutional ownership at this time.Read more about Surgery Partners' insider trading history. Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGRY Stock News HeadlinesSurgery Partners (SGRY): Buy, sell, or hold post Q2 earnings?September 23 at 9:53 AM | msn.comSurgery Partners closes $800 million deal for Idaho hospitalsSeptember 22 at 2:42 PM | bizjournals.comThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about what $375,000 did five years ago, even though no statement shows the change. Central banks have bought over 1,000 tonnes of gold a year for three straight years, using the same published data now explained in a free guide. The guide breaks down what's driving the shift in plain English, so readers can see the numbers for themselves.September 24 at 1:00 AM | American Alternative (Ad)TD Cowen Reiterates Buy Rating for Surgery Partners (NASDAQ:SGRY)September 20, 2026 | americanbankingnews.com(SGRY) Surgery Partners Expects 2026 Revenue Range $3.08B to $3.18B, vs. FactSet Est of $3.42BSeptember 17, 2026 | marketscreener.comMSurgery Partners Lowers 2026 Revenue Guidance; Completes $797 Million Sale of Idaho Falls FacilitiesSeptember 17, 2026 | finance.yahoo.comSurgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the TransactionSeptember 17, 2026 | globenewswire.comSurgery Partners (SGRY) Q2 2026 Earnings Call TranscriptAugust 18, 2026 | finance.yahoo.comSee More Headlines SGRY Stock Analysis - Frequently Asked Questions How have SGRY shares performed this year? Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY shares have decreased by 7.5% and is now trading at $14.2870. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Monday, August, 10th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.06 by $0.04. The company's revenue for the quarter was up 2.7% on a year-over-year basis. Read the conference call transcript. Is Surgery Partners doing a stock buyback? Surgery Partners' board initiated a stock repurchase plan on Thursday, February 26th 2026, which authorizes the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 9.7% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its stock is undervalued. When did Surgery Partners IPO? Surgery Partners (SGRY) raised $350 million in an initial public offering on Thursday, October 1st 2015. The company issued 14,285,000 shares at $23.00-$26.00 per share. Who are Surgery Partners' major shareholders? Surgery Partners' top institutional shareholders include Jupiter Topco LLC (10.60%), Pentwater Capital Management LP (8.88%), BlackRock Inc. (4.77%) and Hsbc Holdings PLC (2.26%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, David T Doherty, Wayne S Deveydt, Harrison R Bane, Marissa Brittenham, Danielle Burkhalter, William Trenton Webb, Bradley R Owens and Teresa Deluca. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE). Company Calendar Last Earnings8/10/2026Today9/24/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 2 days ago, SGRY's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Facilities Current SymbolNASDAQ:SGRY CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees16,000Year Founded2004Price Target and Rating Average Price Target for Surgery Partners$19.00 High Price Target$30.00 Low Price Target$14.00 Potential Upside/Downside+34.1%Consensus RatingModerate Buy Rating Score (0-4)2.55 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($0.70) Trailing P/E RatioN/A Forward P/E Ratio56.66 P/E Growth4.89Net Income-$77.90 million Net Margins-2.63% Pretax Margin3.04% Return on Equity0.88% Return on Assets0.34% Debt Debt-to-Equity Ratio1.18 Current Ratio1.95 Quick Ratio1.78 Sales & Book Value Annual Sales$3.31 billion Price / Sales0.56 Cash Flow$1.53 per share Price / Cash Flow9.26 Book Value$24.21 per share Price / Book0.59Miscellaneous Outstanding Shares130,920,000Free Float128,300,000Market Cap$1.85 billion OptionableOptionable Beta1.92 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:SGRY) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe Pentagon Has 120 Days to Solve This Critical Mineral ProblemChina controls roughly 80% of the world's tungsten supply, and new Pentagon sourcing restrictions take effect ...The Tomorrow Investor | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredWall Street Legend: “I've discovered a fatal flaw built into Elon's AI model”Wall Street veteran Marc Chaikin says he's found a fatal flaw built into Elon Musk's AI model and every fronti...Chaikin Analytics | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGRY Stock Alerts